Assuming you are a VC investor in healthcare. Let me know which of these two email templates below interests you the most if any.
Dear David
We have a unique approach to cancer drug discovery that will reduce timelines for cancer treatment developments by enhancing access to critical research and data. Current delays in information impact the timing of drugs which will mean life or death for millions of people each year. Most innovative cancer drugs are facing delays in reaching patients, because regulators are not keeping up with the pace of progress along with the shortage of human resources leading to delays from patent to patients, for current cancer patients a delay of just a few weeks could mean life or death.
We are solving this issue by building a platform where researchers and scientists freely exchange ideas, data, and information related to cancer. This unrestricted access removes barriers and allows specialists from diverse fields to build on each other’s work,
I would like an opportunity to have a call with you and show you how this works
How about this Thursday at 3:30 pm?
Emmanuel.
Vs
Subj: Seek advice
Hello Mr/Mrs X
The current landscape of cancer treatment development is marked by significant delays, jeopardizing the lives of millions of patients. The challenges, ranging from regulatory hurdles to resource shortages, have prompted us to devise a unique approach that accelerates the exchange of crucial research and data among scientists and researchers.
By creating an environment that fosters open collaboration, which no one is doing, we break down barriers and expedite the journey from patent to patients allowing scientists to build on each other’s work. This is especially crucial for cancer patients, where even a brief delay could be a matter of life or death.
Our approach has the potential to make a substantial impact on the timely delivery of groundbreaking cancer treatments.
The purpose of this message is to ask for an opportunity to meet you and show how this works How about this Thursday at 3:30 pm?
Emmanuel
That sounds like extra work, for people already very busy.
In most cases, especially in well established fields, there’s a reason why certain things aren’t being done. Ranging from that it can’t be done, perhaps for legal reasons, all the way to the people involved straight up resisting any form of changes to their current tools and routines.
That sounds like extra work, and it sounds like something five out of four legal advisors will shutdown at a very early stage. (Because in healthcare and IP there’s a surplus of 'em.)
All in all I’d expect anyone that could get interested to want to know a lot more before wanting to book a meeting.
Ideally your message should be a lot shorter. Like a short tl;dr, followed by a pitch deck that actually works inline in that same email (on a small phone as well as a laptop).
We’re talking 2-3 very short sentences that instantly tell the reader “we do this revolutionary thing”, followed by a deck that clearly show what you’ve got.
At each stage you get more and more time before you lose your audience before they get to whatever point it is that you’re trying to make, but it starts at almost zero time. It starts with the subject line to even get them to open your email, and then you only get those first few sentences to convince them to not go with the default action of deleting yet another spam/cold email. Each stage is a sales pitch just to get them to the next stage, where you get a little bit more time before you lose them.
Personally my default reaction to a too specific date and time is a no, simply because odds are that I can’t instantly commit with a yes.
I tend to react more positively to questions that I can’t easily answer before mentally having come up with the answer that the other person want, like asking me when it at the earliest would be the most convenient for me to do a quick meeting.
u/No_Importance_2338 appreciate the feedback, what do you both think of this?
Hi David,
We developed a method of finding cancer treatments that shortens the time needed to create new drugs by over 90% compared to the usual speed-to-market. The majority of novel cancer treatments are taking longer to get to patients. The most promising new treatments have not been effectively fast-tracked because regulators have not been able to keep up with the rate of advancement. In this business, a few weeks’ delay can mean the difference between life and death for hundreds of thousands of people.
Our goal at MedAI is to reduce the average 10–13-year treatment adoption process to 1-2 years by facilitating collaboration between pharmaceutical companies in countries with severe and lengthy treatment adoption processes and those with fewer and accommodating limitations.
This method benefits around 21 million people each year in a global market worth approximately $180 billion.
I would like to opportunity to show you how this works over a Zoom call, Please let me know what day and time this week works best for you.
Best,
Emmanuel.